|
Proteintech
anti nf κb p65 Anti Nf κb P65, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p65/NF-%CE%BAB+p65+Antibody/pmc13760777-140-4-27 Average 96 stars, based on 1 article reviews
anti nf κb p65 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
rela Rela, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p65/NF%CE%BAB+p65+Antibody/10__1038_slash_s41598___026___79156___z-54-61-63 Average 96 stars, based on 1 article reviews
rela - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Proteintech
nf κb ![]() Nf κb, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p65/NF-%CE%BAB+p65+Polyclonal+antibody/pmc13756838-72-16-27 Average 96 stars, based on 1 article reviews
nf κb - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
phospho p65 ser536 ![]() Phospho P65 Ser536, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p65/Phospho-NF-kappaB+p65+(Ser536)+Rabbit+mAb/pmc13754450-58-28-30 Average 99 stars, based on 1 article reviews
phospho p65 ser536 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
antibodies against phospho nf κb p65 ![]() Antibodies Against Phospho Nf κb P65, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p65/Phospho-NF-kappaB+p65+(Ser536)+Rabbit+mAb/pmc13753654-152-16-21 Average 99 stars, based on 1 article reviews
antibodies against phospho nf κb p65 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ABclonal Biotechnology
phospho nf κb ![]() Phospho Nf κb, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p65/Phospho-NF-kB+p65-S536+Rabbit+pAb/pm42962328-167-15-20 Average 96 stars, based on 1 article reviews
phospho nf κb - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
phospho nf κb p65 ser536 antibody ![]() Phospho Nf κb P65 Ser536 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p65/Phospho-NF-kB+p65+(Ser536)+Rabbit+mAb/pmc13748887-289-4-27 Average 96 stars, based on 1 article reviews
phospho nf κb p65 ser536 antibody - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Elabscience Biotechnology
nf κb p65 polyclonal antibody ![]() Nf κb P65 Polyclonal Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p65/NF%CE%BAB-p65+Polyclonal+Antibody/pmc13748922-115-2-5 Average 94 stars, based on 1 article reviews
nf κb p65 polyclonal antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
nf kb p65 rabbit monoclonal antibody ![]() Nf Kb P65 Rabbit Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p65/NF-kappaB+p65+Rabbit+mAb/pmc13748887-289-8-27 Average 96 stars, based on 1 article reviews
nf kb p65 rabbit monoclonal antibody - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
phospho nf κb ![]() Phospho Nf κb, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/p65/Phospho-NF-kappaB+p65+(Ser536)+Rabbit+mAb/pmc13765516-160-44-45 Average 99 stars, based on 1 article reviews
phospho nf κb - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
Journal: Immunity, Inflammation and Disease
Article Title: Jiawei Duhuo Jisheng Mixture Alleviates Knee Osteoarthritis via Inhibition of TLR4/MyD88/NF‐κB Signaling and Is Associated With Gut Microbiota Alterations
doi: 10.1002/iid3.70586
Figure Lengend Snippet: JDJM alleviates rabbit KOA by suppressing the TLR4/MyD88/NF‐κB signaling cascade. (A and B) Protein expression of TLR4, MyD88, and NF‐κB was determined by Western blotting, with β‐actin used as the loading control ( n = 3 animals/group). (C) The mRNA levels of TLR2, TLR4, MyD88, and NF‐κB were measured by RT‐qPCR ( n = 3 animals/group). (D) Representative immunofluorescence images of NF‐κB p65 intracellular distribution were obtained from n = 2 animals/group at 400× magnification; these images were used for qualitative assessment only and were not subjected to inferential statistical analysis. Each quantitative data point represents an individual animal. Data are presented as mean with 95% CI. Differences among groups were analyzed by one‐way ANOVA followed by Tukey's multiple‐comparisons test. * p < 0.05 versus BC; # p < 0.05 versus MC. Exact p values for the specified pairwise comparisons are provided.
Article Snippet: The primary antibodies applied in this study were directed against TLR2 (66645‐1‐Ig), TLR4 (19811‐1‐AP), MyD88 (23230‐1‐AP),
Techniques: Expressing, Western Blot, Control, Quantitative RT-PCR, Immunofluorescence, Analysis
Journal: Immunity, Inflammation and Disease
Article Title: Jiawei Duhuo Jisheng Mixture Alleviates Knee Osteoarthritis via Inhibition of TLR4/MyD88/NF‐κB Signaling and Is Associated With Gut Microbiota Alterations
doi: 10.1002/iid3.70586
Figure Lengend Snippet: Molecular docking of JDJM constituents with proteins associated with the TLR4/MyD88/NF‐κB signaling pathway. (A) Heatmap of AutoDock Vina scores for 21 identified JDJM constituents against the TLR4/MD‐2 complex, MyD88, and NF‐κB p65. More negative values indicate more favorable predicted docking poses within the same target. (B–D) Representative docking poses of wogonoside with TLR4/MD‐2 (−8.417 kcal/mol), baicalin with MyD88 (−7.919 kcal/mol), and glycyrrhizic acid with NF‐κB p65 (−8.573 kcal/mol), respectively. Green dashed lines indicate predicted polar contacts.
Article Snippet: The primary antibodies applied in this study were directed against TLR2 (66645‐1‐Ig), TLR4 (19811‐1‐AP), MyD88 (23230‐1‐AP),
Techniques: Docking Assay
Journal: Immunity, Inflammation and Disease
Article Title: Jiawei Duhuo Jisheng Mixture Alleviates Knee Osteoarthritis via Inhibition of TLR4/MyD88/NF‐κB Signaling and Is Associated With Gut Microbiota Alterations
doi: 10.1002/iid3.70586
Figure Lengend Snippet: Gut microbiota alterations in KOA rabbits and the effects of JDJM treatment. (A) Spearman's correlation analysis between gut microbiota features and inflammatory indicators and TLR4/MyD88/NF‐κB‐related molecules. (B) Venn diagram showing shared and unique amplicon sequence variants (ASVs) across groups. (C) Genus‐level taxonomic composition based on relative abundance. (D) LEfSe analysis identifying differentially abundant taxa across groups. 16S rRNA gene sequencing was performed using n = 3 animals/group, with each sample derived from an individual animal.
Article Snippet: The primary antibodies applied in this study were directed against TLR2 (66645‐1‐Ig), TLR4 (19811‐1‐AP), MyD88 (23230‐1‐AP),
Techniques: Analysis, Amplification, Sequencing, Derivative Assay, Quantitative RT-PCR, Western Blot
Journal: Cancer Science
Article Title: SNRPC ‐ DHX9 ‐ RelA Complex Drives Cell‐Cycle Signaling and CDK4 /6 Inhibitor Sensitivity in Hepatocellular Carcinoma
doi: 10.1111/cas.70589
Figure Lengend Snippet: SNRPC regulates cell‐cycle distribution and NF‐κB signaling in vitro. (A) Flow‐cytometric analysis of apoptosis in SK‐Hep1 cells transfected with sh‐NC, shSNRPC#, or shSNRPC##, with corresponding quantitative analysis ( n = 3). Data are presented as the mean ± SD; three‐group comparisons were performed using one‐way ANOVA followed by Tukey's multiple‐comparisons test. (B) Flow‐cytometric analysis of cell‐cycle distribution in SK‐Hep1 cells transfected with sh‐NC or shSNRPC#, with corresponding quantification of the G0/G1, S, and G2/M fractions ( n = 3). Data are presented as the mean ± SD; two‐group comparisons were performed using two‐tailed unpaired Student's t ‐tests. (C) TIMER database analyses showing correlations between SNRPC expression and CDK4, CDK6, and E2F1 in LIHC. (D) TIMER analysis of the correlation between SNRPC and RELA expression in LIHC after adjustment for tumor purity. (E, F) Western blot analysis of p‐p65, p65, MMP2, MMP9, PCNA, Cyclin D1, CDK4, CDK6, and E2F1 following SNRPC knockdown or overexpression ( n = 3). (G) Representative immunofluorescence images showing phospho‐p65 (Ser536) localization in SK‐Hep1 cells following SNRPC knockdown ( n = 3). Scale bar = 50 μm.
Article Snippet: Equal amounts of protein (30 μg) were separated by SDS‐PAGE, transferred to PVDF membranes, and immunoblotted using antibodies against SNRPC (Abcam, ab192028), DHX9 (Proteintech, 17721–1–AP), p65 (Abcam, ab32536),
Techniques: In Vitro, Analysis, Transfection, Two Tailed Test, Expressing, Western Blot, Knockdown, Over Expression, Immunofluorescence
Journal: Cancer Science
Article Title: SNRPC ‐ DHX9 ‐ RelA Complex Drives Cell‐Cycle Signaling and CDK4 /6 Inhibitor Sensitivity in Hepatocellular Carcinoma
doi: 10.1111/cas.70589
Figure Lengend Snippet: SNRPC, DHX9, and RelA form a pro‐oncogenic ternary complex in the nucleus. (A) Prediction of DHX9 as a potential interacting partner of SNRPC using the STRING database. (B‐D) Schematic diagrams illustrating the binding mode and predicted interaction sites between SNRPC and DHX9. (E‐G) Schematic diagrams illustrating the binding mode and predicted interaction sites between DHX9 and RelA/p65. (H) Immunofluorescence images showing nuclear co‐localization of SNRPC and DHX9 in Hep G2 cells. Scale bar = 50 μm. (I) Endogenous co‐immunoprecipitation analysis of the interactions among SNRPC, DHX9, and RelA/p65. (J) Sequential co‐immunoprecipitation analysis of the SNRPC‐DHX9‐RelA/p65 ternary complex. (K) Schematic diagrams illustrating the constructs of DHX9 wild‐type (WT) and the K417R mutant. (L) Western blot analysis of total and phosphorylated p65 (p‐p65 Ser536) in L‐02 and Hep G2 cells following transfection with DHX9‐WT or DHX9‐K417R plasmids.
Article Snippet: Equal amounts of protein (30 μg) were separated by SDS‐PAGE, transferred to PVDF membranes, and immunoblotted using antibodies against SNRPC (Abcam, ab192028), DHX9 (Proteintech, 17721–1–AP), p65 (Abcam, ab32536),
Techniques: Binding Assay, Immunofluorescence, Co-Immunoprecipitation Assay, Analysis, Construct, Mutagenesis, Western Blot, Transfection
Journal: Cancer Science
Article Title: SNRPC ‐ DHX9 ‐ RelA Complex Drives Cell‐Cycle Signaling and CDK4 /6 Inhibitor Sensitivity in Hepatocellular Carcinoma
doi: 10.1111/cas.70589
Figure Lengend Snippet: DHX9 functions as an oncogenic cofactor to promote HCC progression via NF‐κB‐associated cell‐cycle regulation. (A) Pan‐cancer analysis of DHX9 expression using TIMER. (B) Comparison of DHX9 expression between HCC and normal liver tissues using GEPIA (TCGA‐LIHC tumors, n = 369; TCGA/GTEx normal liver tissues, n = 160). (C) Representative HPA immunohistochemistry images showing DHX9 protein staining in normal liver and HCC tissues. (D) HPA immunofluorescence images showing subcellular localization of DHX9 in U‐251MG cells. (E) Association between DHX9 expression and pathological stage using GEPIA. (F) GEPIA Kaplan–Meier overall‐survival analysis (DHX9‐high, n = 91; DHX9‐low, n = 91). (G) TIMER correlations between DHX9 and CDK4, CDK6, and E2F1 in LIHC. (H) TIMER tumor‐purity‐adjusted correlation between DHX9 and RELA. (I, J) Flow‐cytometric analysis and quantification of cell‐cycle distribution in SK‐Hep1 cells transfected with sh‐NC, sh‐DHX9#, or sh‐DHX9## ( n = 3). Data are presented as the mean ± SD. (K) Western blot analysis of DHX9, p‐p65, p65, CDK4, CDK6, Cyclin D1, and PCNA following DHX9 knockdown. (L) Representative immunofluorescence images showing p‐p65 (Ser536) after DHX9 knockdown ( n = 3). Scale bar = 50 μm. * p < 0.05.
Article Snippet: Equal amounts of protein (30 μg) were separated by SDS‐PAGE, transferred to PVDF membranes, and immunoblotted using antibodies against SNRPC (Abcam, ab192028), DHX9 (Proteintech, 17721–1–AP), p65 (Abcam, ab32536),
Techniques: Analysis, Expressing, Comparison, Immunohistochemistry, Staining, Immunofluorescence, Transfection, Western Blot, Knockdown
Journal: Cancer Science
Article Title: SNRPC ‐ DHX9 ‐ RelA Complex Drives Cell‐Cycle Signaling and CDK4 /6 Inhibitor Sensitivity in Hepatocellular Carcinoma
doi: 10.1111/cas.70589
Figure Lengend Snippet: CDK4/6 inhibition suppresses SNRPC‐ and DHX9‐driven HCC tumor growth in vivo. (A) Representative images of tumor‐bearing mice from vector control, SNRPC‐overexpressing, and DHX9‐overexpressing groups, with or without palbociclib treatment as indicated. (B) Representative images of excised xenograft tumors and corresponding tumor weights from the indicated groups ( n = 6 mice per group). Data are presented as the mean ± SD. Statistical comparisons among groups were performed using one‐way ANOVA followed by Tukey's multiple‐comparisons test, and exact adjusted p values are shown in the graphs. (C, D) Representative immunohistochemical staining for Ki‐67, CDK4, CDK6, and E2F1 in xenograft tumors from the indicated SNRPC and DHX9 experimental groups, with or without palbociclib treatment. Scale bar = 200 μm. (E) Western blot analysis of Ki‐67, CDK4, CDK6, and E2F1 in xenograft tumor lysates from the indicated groups. (F) Schematic model illustrating the proposed SNRPC‐DHX9‐RelA/p65 signaling mechanism. SNRPC interacts with DHX9 and RelA/p65 to form a nuclear complex that enhances NF‐κB signaling and promotes activation of the CDK4/6‐E2F1 axis, thereby contributing to HCC cell proliferation and tumor progression.
Article Snippet: Equal amounts of protein (30 μg) were separated by SDS‐PAGE, transferred to PVDF membranes, and immunoblotted using antibodies against SNRPC (Abcam, ab192028), DHX9 (Proteintech, 17721–1–AP), p65 (Abcam, ab32536),
Techniques: Inhibition, In Vivo, Plasmid Preparation, Control, Xenograft Assay, Immunohistochemical staining, Staining, Western Blot, Analysis, Activation Assay
Journal: Journal of Biochemical and Molecular Toxicology
Article Title: Targeting TLR2 to Overcome Autophagy‐Dependent Chemoresistance in Gastric Cancer: Integrating Molecular Docking, Mechanistic Validation, and Therapeutic Evaluation
doi: 10.1002/jbt.71137
Figure Lengend Snippet: Nilotinib and Lomitapide modulated the protein and mRNA levels of autophagy‐related factors and activated transcription factors in GC cells. (A) Representative western blot bands showing protein levels of different autophagy‐related factors in GC cells treated in different conditions. (B) Analysis of western blot bands showing protein levels of different autophagy‐related factors. Data were analyzed using one‐way ANOVA followed by Tukey's post hoc tests. (C) Analysis of mRNA levels of different autophagy‐related factors in GC cells in different treatment groups. Data were analyzed using one‐way ANOVA followed by Tukey's post hoc tests. Data are presented as mean ± SD from three independent experiments. Ns; nonsignificant, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus the MKN‐45 control group and # p < 0.05, ## p < 0.01, ### p < 0.001, #### p < 0.0001.
Article Snippet: To assess signaling pathways, activation of NF‐κB and MAPK pathways was also assessed by immunoblotting using
Techniques: Western Blot, Analysis, Control, Gene Expression
Journal: Chemistry & Biodiversity
Article Title: The Cardioprotective Potential of Red Onion Waste Against Isoprenaline‐Induced Myocardial Infarction in Rat: Molecular Docking and In Vivo Studies
doi: 10.1002/cbdv.71904
Figure Lengend Snippet: Effect of red onion scales extract on inflammatory markers; Figures (A‐F) represent NF‐κB (p65) expression. The photomicrographs exhibited the expression as the following: (A) Control, (B) Red onion 300, (C) ISO, (D) Red onion 150+ISO, (E) Red onion 300+ISO, and (F) The immunohistochemical expression as area%, as well as (G) IL‐ 1β . For 30 days, red onion scales extract was administered (150/300 mg/kg; p.o.), while ISO (65 mg/kg; s.c.) was injected on days 29 and 30 to induce MI, Results were presented as mean ± standard deviation (n = 4 per group). Data was analyzed using one‐way analysis of variance (ANOVA) followed by Tukey's multiple comparisons test. The significant differences were set at ( p < 0.05) among all groups. a significantly different from the control group, b significantly different from the ISO group, and c significantly different from the red onion 150+ISO group. IL‐1β: Interleukin‐1 beta; ISO: Isoprenaline; MI: Myocardial infarction; NF‐κB: Nuclear factor kappa B.
Article Snippet: Rabbit Anti
Techniques: Expressing, Control, Immunohistochemical staining, Injection, Standard Deviation, Analysis